Related Experiment Video
Updated: Apr 26, 2026

08:49
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
8.9K
Discovery libraries targeting the major enzyme classes: the serine hydrolases
Katerina Otrubova1, Venkat Srinivasan1, Dale L Boger1
1Department of Chemistry and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla CA 92037, United States.
Bioorganic & Medicinal Chemistry Letters
|July 20, 2014
Summary
Researchers developed novel urea compounds as potential serine hydrolase inhibitors. Pyrazole-based ureas showed potent inhibition of fatty acid amide hydrolase (FAAH), offering new therapeutic avenues.
Area of Science:
- Medicinal Chemistry
- Enzyme Inhibition
Background:
- Serine hydrolases are crucial drug targets.
- Fatty acid amide hydrolase (FAAH) plays a role in various physiological processes.
- Developing selective inhibitors for serine hydrolases is an ongoing challenge.
Purpose of the Study:
- To synthesize and screen libraries of novel urea-based compounds.
- To identify potent inhibitors of serine hydrolases, particularly FAAH.
- To explore structure-activity relationships for further drug development.
Main Methods:
- Preparation of two distinct urea compound libraries: one with electron-deficient acyl anilines and another with acyl pyrazoles.
- Utilizing these libraries for fragment-based screening.
- Elaboration of promising pyrazole-based scaffolds.
Main Results:
- Successful synthesis of two novel urea libraries.
- Identification of a subset of compounds suitable for fragment screening and structural diversification.
- Discovery of highly potent irreversible inhibitors of fatty acid amide hydrolase (FAAH) derived from pyrazole-based ureas, with apparent Ki values in the picomolar range.
- These pyrazole-based inhibitors are complementary to previously reported aniline-based inhibitors.
Conclusions:
- Novel urea scaffolds can be effectively employed for serine hydrolase inhibition.
- Pyrazole-based ureas represent a promising chemotype for developing potent FAAH inhibitors.
- The identified inhibitors offer a foundation for further optimization and therapeutic applications targeting FAAH-related conditions.

